 Kianifard et al,227 72 patients with
C2 disease were treated with HL&S 6 phlebectomy, 38
also underwent the SEPS procedure. At 1 year, no additional clinical beneﬁt could be observed, when SEPS was
added to HL&S. It should therefore be emphasized that
SEPS or any other technique for perforator treatment
concomitant with initial superﬁcial axial reﬂux treatment
in